MedPath

VOLIBRIS 2,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

VOLIBRIS 2,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

Commercialized
Register Number

108451005

Prescription Type

Uso Hospitalario

Authorization Date

Oct 19, 2021

Dosage Form

COMPRIMIDO RECUBIERTO CON PELÍCULA

Route: VÍA ORAL

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number108451005
EMA Approved
Yes

Drug Classification

Generic
No
Orphan
No
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (1)

AMBRISENTANActive
Quantity: 2,5 mg
Name: AMBRISENTAN

ATC CLASSIFICATION (3)

C02K
C02KX
C02KX02

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.